Streetbeat News

Products Services

DXCM

Dexcom has launched Stelo, the first over-the-counter glucose biosensor in the U.S., available without a prescription. It targets adults with Type 2 diabetes not using insulin and those with prediabetes, providing 24/7 glucose insights via smartphone.

Portfolio Pulse from Benzinga Newsdesk

August 26, 2024 | 1:22 pm

LQDT

Liquidity Services has partnered with Aaron Industrial Solutions to sell unused assets for a global energy leader in China. The sale includes over 60 Sumimoto cryogenic heat exchangers available on AllSurplus.com until August 31, 2024.

Portfolio Pulse from Benzinga Newsdesk

August 26, 2024 | 1:12 pm

PLRX

Pliant Therapeutics, Inc. (NASDAQ:PLRX) will present four upcoming presentations at the ERS International Congress 2024, focusing on their advancements in fibrotic disease therapeutics.

Portfolio Pulse from Benzinga Newsdesk

August 26, 2024 | 1:11 pm

GLDD

Great Lakes Dredge & Dock Corporation has secured $256.2 million in dredging awards for projects including Mobile Harbor, Port Everglades, Long Beach Island, Fire Island, North Wildwood, and St. Lucie Inlet.

Portfolio Pulse from Benzinga Newsdesk

August 26, 2024 | 1:06 pm

TCJH

Top Kingwin has established a new subsidiary, Shenzhen Tomorrow Innovation, to focus on developing advanced AI hardware supply chains and intelligent systems. This move aims to accelerate digital transformation for enterprises.

Portfolio Pulse from Benzinga Newsdesk

August 26, 2024 | 1:05 pm

CART

UBER

The article discusses how Instacart's future could be significantly influenced by Uber's strategic decisions. It highlights the potential for collaboration or competition between the two companies, which could impact Instacart's market position.

Portfolio Pulse from Benzinga Newsdesk

August 26, 2024 | 1:02 pm

UFPT

UFP Technologies, Inc. (NASDAQ:UFPT) has acquired AQF Medical, a company specializing in custom-engineered foam and thermoplastic components for medical devices and packaging. The financial terms of the acquisition were not disclosed.

Portfolio Pulse from Benzinga Newsdesk

August 26, 2024 | 1:01 pm

XPEV

XPeng Inc (NYSE:XPEV) saw its stock rise over 5% in premarket trading after CEO Xiaopeng acquired over 2 million shares, signaling confidence in the company's growth. Despite a 60.2% year-on-year revenue increase, XPeng missed analyst estimates. The stock has dropped 62% over the past year due to weak demand and tariffs.

Portfolio Pulse from Anusuya Lahiri

August 26, 2024 | 1:00 pm

NVS

Siemens Healthineers is acquiring Novartis' diagnostics arm for $223.5 million to enhance its cancer treatment capabilities, particularly in PET scans. This acquisition will expand Siemens' PET radiopharmaceuticals business into Europe, strengthening its market position. Novartis views the sale as a divestiture of a low-growth segment.

Portfolio Pulse from Vandana Singh

August 26, 2024 | 12:54 pm

BIIB

LLY

Eli Lilly's Alzheimer's drug, donanemab, is likely to face rejection by the UK's NHS due to safety concerns and high costs, following a similar rejection of Biogen's lecanemab. Despite donanemab's effectiveness, its side effects and projected higher costs pose significant hurdles.

Portfolio Pulse from Vandana Singh

August 26, 2024 | 12:45 pm